Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
Cancer treatment center in Decatur, Illinois
210 W McKinley Ave Ste 1, Decatur, IL 62526
About Cancer Care Specialists of Illinois - Decatur
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
135
SWOG Cancer Research Network
58
Alliance for Clinical Trials in Oncology
38
ECOG-ACRIN Cancer Research Group
24
NRG Oncology
13
Wake Forest University Health Sciences
7
GOG Foundation
4
Children's Oncology Group
3
Gynecologic Oncology Group
3
Eastern Cooperative Oncology Group
2
Jounce Therapeutics, Inc.
1
Clinical Trials at Cancer Care Specialists of Illinois - Decatur
During the past decade, Cancer Care Specialists of Illinois - Decatur conducted 198 clinical trials. In the 10-year time frame, 198 clinical trials started and 95 clinical trials were completed, i.e. on
average, 48% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 66 clinical trials were completed. i.e. 89.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
2006-06-01
2011-07-01
Completed
41
S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
2007-03-01
2014-01-01
Completed
85
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
2007-07-01
2014-01-01
Completed
89
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
2008-03-01
2014-02-25
Completed
134
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cancer Care Specialists of Illinois - Decatur" #1 sponsor was "National Cancer Institute (NCI)" with 135 trials, followed by "SWOG Cancer Research Network" with 58 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 38 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 24 trials sponsored and "NRG Oncology"
with 24 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Specialists of Illinois - Decatur"
#1 collaborator was "National Cancer Institute (NCI)" with 151 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 13 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were
collaborators in the rest 28 trials.
Clinical Trials Conditions at Cancer Care Specialists of Illinois - Decatur
According to Clinical.Site data, the most researched conditions in "Cancer Care Specialists of Illinois - Decatur" are
"Stage IV Lung Cancer AJCC v8" (14 trials), "Recurrent Lung Non-Small Cell Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Stage IVA Lung Cancer AJCC v8" (10 trials). Many other conditions were trialed in "Cancer Care Specialists of Illinois - Decatur" in a lesser frequency.
Clinical Trials Intervention Types at Cancer Care Specialists of Illinois - Decatur
Most popular intervention types in "Cancer Care Specialists of Illinois - Decatur" are "Drug" (219 trials), "Other" (179 trials), "Biological" (113 trials), "Procedure" (83 trials) and "Radiation" (42 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (76 trials), "Laboratory Biomarker Analysis" (74 trials), "Questionnaire Administration" (57 trials), "Computed Tomography" (45 trials) and "Biospecimen Collection" (41 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer Care Specialists of Illinois - Decatur
The vast majority of trials in "Cancer Care Specialists of Illinois - Decatur" are
242 trials for "All" genders, 39 trials for "Female" genders and 8 trials for "Male" genders.
Clinical Trials Status at Cancer Care Specialists of Illinois - Decatur
Currently, there are NaN active trials in "Cancer Care Specialists of Illinois - Decatur".
undefined are not yet recruiting,
99 are recruiting,
123 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 50 completed trials in Cancer Care Specialists of Illinois - Decatur,
9 suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Care Specialists of Illinois - Decatur, 11 "Phase 1"
clinical trials were conducted, 155 "Phase 2" clinical
trials and 129 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 10 trials that are defined as “Not Applicable".